1954 - Immunogenicity against SARS CoV-2 ancestral strain and variants of two new COVID-19 recombinant adjuvanted vaccines compared to BNT162b2 as a third dose following two doses of BNT162b2: a single-blinded multicenter randomized controlled trial

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

OL

Odile Launay, MD, PhD

Head of I Reivac, French vaccine research network
Université Paris Cité; Inserm F-CRIN, I-REIVAC; Assistance Publique Hôpitaux de Paris
Paris, Ile-de-France, France

Co-Author(s)

MC

Marine Cachanado, Msc

Department of Clinical Pharmacology and Clinical Research Platform Paris-East (URCEST-CRC-CRB), APHP, Hôpital St Antoine, Paris, France
Paris, Ile-de-France, France
LL

Liem Binh Luong, MD

AP-HP, Hôpital Cochin; Inserm CIC 1417, Paris, France; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France
Paris, Ile-de-France, France
LN

Laetitia Ninove, MD

Unité des Virus Emergents, UVE : Aix Marseille Univ, IRD 190, INSERM 1207, IHU Méditerranée Infection, 13005, Marseille, France
Marseille, Provence-Alpes-Cote d'Azur, France
ML

Marie Lachâtre, MD

AP-HP, Hôpital Cochin; Inserm CIC 1417, Paris, France; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France
Paris, Ile-de-France, France
IB

Inès Ben Ghezala, MD

Inserm, CIC 1432, Clinical Investigation Center, Clinical Epidemiology/Clinical Trials Unit, University Hospital, Dijon, France; F-CRIN, I REIVAC/COVIREIVAC, France
Dijon, Bourgogne, France
MB

Marc Bardou, MD, PhD

Inserm, CIC 1432, Clinical Investigation Center, Clinical Epidemiology/Clinical Trials Unit, University Hospital, Dijon, France; F-CRIN, I REIVAC/COVIREIVAC, France
Dijon, Bourgogne, France
CS

Catherine Schmidt-Mutter, MD, PhD

CIC Inserm 1434, Hôpitaux Universitaires de Strasbourg, France.; F-CRIN, I REIVAC/COVIREIVAC, France
Strasbourg, Alsace, France
KL

Karine Lacombe, MD, PhD

Sorbonne Inserm UMR-S1136, Hôpital St Antoine, AP-HP, Paris, France; F-CRIN, I REIVAC/COVIREIVAC, France
Paris, Ile-de-France, France
FL

Fabrice Laine, MD, PhD

INSERM, CIC1414, CHU Rennes, Rennes, France; F-CRIN, I REIVAC/COVIREIVAC, France
Rennes, Bretagne, France
JA

Jean-Sébastien Allain, MD

INSERM, CIC1414, CHU Rennes, Rennes, France; F-CRIN, I REIVAC/COVIREIVAC, France
Rennes, Bretagne, France
EB

Elisabeth Botelho-Nevers, MD, PHD

Service d’infectiologie, CIC1408, Inserm, CHU de Saint-Etienne, 42055 Saint-Etienne, France; F-CRIN, I REIVAC/COVIREIVAC, France
Saint Etienne, Auvergne, France
MT

Marie-Pierre Tavolacci, MD, PHD

Normandie Univ, UNIROUEN, U1073, CHU Rouen, and CIC-CRB 1404, F-76000 Rouen, France; F-CRIN, I REIVAC/COVIREIVAC, France
Rouen, Haute-Normandie, France
CC

Christian Chidiac, MD, PHD

Prof.
13. Maladies Infectieuses, GHN Croix Rousse, Hospices Civils de Lyon, UFR de Médecine et Maïeutique Lyon Sud Université Claude Bernard Lyon1, Université de Lyon, CIRI PHE3ID, Inserm U1111 UMR5308 - ENS Lyon; F-CRIN, I REIVAC/COVIREIVAC, France
Lyon, Rhone-Alpes, France
PP

Patricia Pavese, MD

Maladies infectieuses et tropicales, CHU de Grenoble Alpes, France; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France
Grenoble, Rhone-Alpes, France
BD

Bertrand Dussol, MD, PHD

CIC 14-09, INSERM - Aix Marseille Université – Hôpitaux Universitaires de Marseille; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France
Marseille, Provence-Alpes-Cote d'Azur, France
SP

Stéphane Priet, PhD

Unité des Virus Émergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France
Marseille, Provence-Alpes-Cote d'Azur, France
DD

Dominique Deplanque, MD, PHD

Univ. Lille, Inserm, CHU Lille, CIC 1403 - Centre d’investigation clinique, F-59000 Lille, France; F-CRIN, I REIVAC/COVIREIVAC, France
Lille, Nord-Pas-de-Calais, France
AT

Amel Touati, VetD

Department of Clinical Pharmacology and Clinical Research Platform Paris-East (URCEST-CRC-CRB), APHP, Hôpital St Antoine, Paris, France
Paris, Ile-de-France, France
LC

Laureen Curci, PharmD

AP-HP, Hôpital Cochin; Inserm CIC 1417, Paris, France; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France
Paris, Ile-de-France, France
EK

Eleine Konate, PharmD

AP-HP, Hôpital Cochin; Inserm CIC 1417, Paris, France; Inserm, F-CRIN, I REIVAC/COVIREIVAC, France
Paris, Ile-de-France, France
NB

Nadine Ben Hamouda, Ing

Service d’Immunologie Biologique, APHP, Hôpital Européen Georges Pompidou, 75015 Paris, France ; PARCC, INSERM U970, Université de Paris, 75006 Paris, France
Paris, Ile-de-France, France
AB

Anissa Besbes, PHD

Service d’Immunologie Biologique, APHP, Hôpital Européen Georges Pompidou, 75015 Paris, France ; PARCC, INSERM U970, Université de Paris, 75006 Paris, France
Paris, Ile-de-France, France
EN

Eunice Nubret, Msc

APHP, Direction de la Recherche Clinique et de l’Innovation (DRCI), Paris, France
Paris, Ile-de-France, France
FC

Florence Capelle, Msc

Département des Essais Cliniques de l’AGEPS, DRCI-APHP, Paris, France
Paris, Ile-de-France, France
LB

Laurence Berard, MD

Department of Clinical Pharmacology and Clinical Research Platform Paris-East (URCEST-CRC-CRB), APHP, Hôpital St Antoine, Paris, France
Paris, Ile-de-France, France
AR

Alexandra Rousseau, PHD

Department of Clinical Pharmacology and Clinical Research Platform Paris-East (URCEST-CRC-CRB), APHP, Hôpital St Antoine, Paris, France
Paris, Ile-de-France, France
ET

Eric Tartour, MD, PHD

Service d’Immunologie Biologique, APHP, Hôpital Européen Georges Pompidou, 75015 Paris, France ; PARCC, INSERM U970, Université de Paris, 75006 Paris, France
Paris, Ile-de-France, France
TS

Tabassome Simon, MD, PHD

Department of Clinical Pharmacology and Clinical Research Platform Paris-East (URCEST-CRC-CRB), APHP, Hôpital St Antoine, Paris, France
Paris, Ile-de-France, France
XD

Xavier De Lamballerie, MD, PHD

Unité des Virus Émergents, UVE: Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France
Marseille, Provence-Alpes-Cote d'Azur, France
RF

Renaud Felten, MD

Inserm CIC 1434, CHU Strasbourg, Strasbourg, F-CRIN, I REIVAC/COVIREIVAC
Strasbourg, Alsace, France
LS

Laure SURGERS, MD

Sorbonne Université, IPLESP Inserm UMR-S1136, Hôpital St Antoine, AP-HP, Paris, France - F-CRIN, I REIVAC/COVIREIVAC
Paris, Ile-de-France, France